rs768083433
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_153240.5(NPHP3):c.45G>T(p.Val15Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000024 in 1,581,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000023 ( 0 hom. )
Consequence
NPHP3
NM_153240.5 synonymous
NM_153240.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.39
Publications
0 publications found
Genes affected
NPHP3 (HGNC:7907): (nephrocystin 3) This gene encodes a protein containing a coiled-coil (CC) domain, a tubulin-tyrosine ligase (TTL) domain, and a tetratrico peptide repeat (TPR) domain. The encoded protein interacts with nephrocystin, it is required for normal ciliary development, and it functions in renal tubular development. Mutations in this gene are associated with nephronophthisis type 3, and also with renal-hepatic-pancreatic dysplasia, and Meckel syndrome type 7. Naturally occurring read-through transcripts exist between this gene and the downstream ACAD11 (acyl-CoA dehydrogenase family, member 11) gene. [provided by RefSeq, Feb 2011]
NPHP3-AS1 (HGNC:24129): (NPHP3 antisense RNA 1)
NPHP3-ACAD11 (HGNC:48351): (NPHP3-ACAD11 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring NPHP3 (nephronophthisis 3, adolescent) and ACAD11 (acyl-CoA dehydrogenase family, member 11) genes on chromosome 3. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 3-132722311-C-A is Benign according to our data. Variant chr3-132722311-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 262715.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.39 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NPHP3 | NM_153240.5 | c.45G>T | p.Val15Val | synonymous_variant | Exon 1 of 27 | ENST00000337331.10 | NP_694972.3 | |
| NPHP3-AS1 | NR_002811.2 | n.562C>A | non_coding_transcript_exon_variant | Exon 1 of 11 | ||||
| NPHP3-ACAD11 | NR_037804.1 | n.149G>T | non_coding_transcript_exon_variant | Exon 1 of 45 | ||||
| NPHP3-AS1 | NR_152743.1 | n.562C>A | non_coding_transcript_exon_variant | Exon 1 of 5 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPHP3 | ENST00000337331.10 | c.45G>T | p.Val15Val | synonymous_variant | Exon 1 of 27 | 1 | NM_153240.5 | ENSP00000338766.5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152036Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
5
AN:
152036
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00000948 AC: 2AN: 211016 AF XY: 0.00000844 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
211016
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000231 AC: 33AN: 1429794Hom.: 0 Cov.: 31 AF XY: 0.0000281 AC XY: 20AN XY: 711764 show subpopulations
GnomAD4 exome
AF:
AC:
33
AN:
1429794
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
711764
show subpopulations
African (AFR)
AF:
AC:
0
AN:
31212
American (AMR)
AF:
AC:
0
AN:
43158
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25596
East Asian (EAS)
AF:
AC:
0
AN:
37716
South Asian (SAS)
AF:
AC:
0
AN:
84318
European-Finnish (FIN)
AF:
AC:
0
AN:
38330
Middle Eastern (MID)
AF:
AC:
0
AN:
4864
European-Non Finnish (NFE)
AF:
AC:
33
AN:
1105134
Other (OTH)
AF:
AC:
0
AN:
59466
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152036Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74236 show subpopulations
GnomAD4 genome
AF:
AC:
5
AN:
152036
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74236
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41418
American (AMR)
AF:
AC:
1
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5150
South Asian (SAS)
AF:
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68004
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.555
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nephronophthisis Benign:1
Feb 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.